The company specializes in transforming collagen tissue into a stabilized collagen matrix, which activates and accelerates the body's natural healing process. Their proprietary technology, BriDGE®, is used to create tissue regeneration products such as Architect® for complex skin wounds and EPMatrix® for soft tissue injuries. These products are designed to support faster and more cost-effective healing of chronic wounds, hernias, joint injuries, and other surgical applications. Harbor MedTech's devices have the potential to be used in various medical fields, including orthopedics, urogynecology, and breast reconstruction. The company was founded in 2010 and is based in Irvine, California. They also have a strategic partnership with Edwards Lifesciences.